7.74 -0.03 (-0.38%)
TSPT
Stock Details
Last Trade:7.74 Change:-0.03 (-0.38%) Prev Close:7.77 Open: 7.84 Days Range:7.56 – 8.00 52 Week Range: 2.56 - 15.40 Volume:7450 P/E: N/AEPS:-2.61
View AllRecent Alerts 02/10/10
Recent Alert on 02/09/10 at 5:40pm
After-Hours Movers 2/9: MCZ, NTGR, CYBI, BIDU, RMTR, FNSR Higher; QUIK, LGF, APPY, VRUS, EXBD Lower
After-Hours Movers 2/9: MCZ, NTGR, CYBI, BIDU, RMTR, FNSR Higher; QUIK, LGF, APPY, VRUS, EXBD Lower
Mad Catz Interactive Inc. (NYSE: MCZ) 36% HIGHER; reports Q3 EPS of $0.09, compared to ($0.49) in the same quarter last year. Revenue for the quarter was $48.8 million, versus $40.8 million in Q309. QuickLogic Corp. (NASDAQ: QUIK) 14.4% LOWER;... Read More
Recent Alert on 02/09/10 at 4:43pm
Transcept Pharmaceuticals (TSPT) Granted U.S. Patent Covering Intermezzo Formulation
Transcept Pharmaceuticals (TSPT) Granted U.S. Patent Covering Intermezzo Formulation
Recent Alert on 12/14/09 at 4:38pm
Transcept Pharma (TSPT) Receives Notice of Allowance for Second Patent Application Covering Intermezzo(R); Eligible for $10M Milestone Payment
Transcept Pharma (TSPT) Receives Notice of Allowance for Second Patent Application Covering Intermezzo(R); Eligible for $10M Milestone Payment
Recent Alert on 12/14/09 at 4:38pm
Transcept Pharma (TSPT) Receives Notice of Allowance for Second Patent Application Covering Intermezzo(R); Eligible for $10M Milestone Payment
Transcept Pharma (TSPT) Receives Notice of Allowance for Second Patent Application Covering Intermezzo(R); Eligible for $10M Milestone Payment
Recent Alert on 11/23/09 at 4:27pm
Transcept Pharma (TSPT) to Meet with U.S. FDA To Discuss NDA Response Letter for Intermezzo
Transcept Pharma (TSPT) to Meet with U.S. FDA To Discuss NDA Response Letter for Intermezzo
View AllRecent Press Releases
Press Release on 02/09/10 at 4:35pm
Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation
Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation
View AllRecent SEC Filings
SEC Filing on 02/09/10 at 2:23pm
Form SC 13D/A Transcept Pharmaceutical Filed by: PROQUEST INVESTMENTS II LP
Form SC 13D/A Transcept Pharmaceutical Filed by: PROQUEST INVESTMENTS II LP
View AllRecent Blog Posts
Blog Posts on 11/01/09 at 4:03am
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
Blog Posts on 10/29/09 at 4:20pm
Closing Bell: Recession-end sells the short-sellers (PG, HGSI, FSLR, AMSC, TSPT)
Closing Bell: Recession-end sells the short-sellers (PG, HGSI, FSLR, AMSC, TSPT)